Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 24 May 2022 for PhaseBio Pharmaceuticals Inc, €7,031. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Susan Elizabeth Arnold: trading record in brief
Susan Elizabeth Arnold is a declared insider of PhaseBio Pharmaceuticals Inc (senior executive), with filings sourced from SEC (Form 4). In total, 5 filings cover trades dated from 20 May 2021 to 20 May 2022.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 24 May 2022: a share grant of €7,031, in PhaseBio Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Susan Elizabeth Arnold
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
10,917 shares@ US$0.681310.5% of flowCommon StockSEC:0001169245-22-000079:0
2,559 shares@ US$2.0115.0% of flowCommon StockSEC:0001169245-21-000128:0
4,519 shares@ US$1.749.9% of flowCommon StockSEC:0001169245-21-000089:0
4,519 shares@ US$1.7421.9% of flowCommon StockSEC:0001169245-21-000069:0
5,257 shares@ US$2.8032.7% of flowCommon StockSEC:0001169245-21-000043:0
5 of 5 declarations
